0001493152-24-033344.txt : 20240820 0001493152-24-033344.hdr.sgml : 20240820 20240820210114 ACCESSION NUMBER: 0001493152-24-033344 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240815 FILED AS OF DATE: 20240820 DATE AS OF CHANGE: 20240820 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CURHAN GREGORY S CENTRAL INDEX KEY: 0001263244 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38519 FILM NUMBER: 241226985 MAIL ADDRESS: STREET 1: 600 CALIFORNIA STREET, 9TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94108 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Serina Therapeutics, Inc. CENTRAL INDEX KEY: 0001708599 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 821436829 STATE OF INCORPORATION: AL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 601 GENOME WAY STREET 2: SUITE 2001 CITY: HUNTSVILLE STATE: AL ZIP: 35806 BUSINESS PHONE: (256) 327-9630 MAIL ADDRESS: STREET 1: 601 GENOME WAY STREET 2: SUITE 2001 CITY: HUNTSVILLE STATE: AL ZIP: 35806 FORMER COMPANY: FORMER CONFORMED NAME: AgeX Therapeutics, Inc. DATE OF NAME CHANGE: 20170606 4 1 ownership.xml X0508 4 2024-08-15 0 0001708599 Serina Therapeutics, Inc. SER 0001263244 CURHAN GREGORY S 601 GENOME WAY, SUITE 2001 HUNTSVILLE AL 35806 0 1 0 0 Chief Financial Officer 0 Stock Option (right to buy) 6.66 2024-08-15 4 A 0 250000 0 A 2024-08-15 Common Stock 250000 250000 D The stock options vest in substantially equal monthly installments beginning on September 15, 2024 such that the stock options shall be fully vested on the fourth anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. /s/ Gregory S. Curhan 2024-08-20